Concepedia

Udi Fainberg

UF

4

Publications

413

Citations

4

H-Index

2019

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Udi Fainberg is an author at Novo Nordisk (Denmark) specializing in metabolic syndrome, medicine, and diabetes.

Top concepts

Publications per year

2019–2022

4

Publications

4

Liraglutide in Children and Adolescents with Type 2 Diabetes

William V. Tamborlane, Margarita Barrientos‐Pérez, Udi Fainberg et al. · New England Journal of Medicine · 2019 · 333 citations · Full text

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial

Lawrence Blonde, Lidia Belousova, Udi Fainberg et al. · Diabetes Obesity and Metabolism · 2020 · 48 citations · Full text

Liraglutide in children and adolescents with type 2 diabetes

Tamborlane Wv, Margarita Barrientos‐Pérez, Udi Fainberg et al. · Yearbook of pediatric endocrinology · 2019 · 18 citations

, , +12

Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk

Jan Westerink, Kasper Sommer Matthiessen, Solomon Nuhoho et al. · Diabetes Care · 2022 · 14 citations · Full text

Rows per page

1–4 of 4